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Volume 60, Number 3 Abstracts 805setting. In addition, they sought to explore the effect of different
methods on the calculated prevalence of AAA using data from a popu-
lation based AAA screening set. One hundred twenty-seven consecutive
patients with small abdominal aortic aneurysms were included.
Maximum anteroposterior diameter was measured using OTO, ITI
and LELE methods by two vascular sonographers blinded to each
other’s measurements. Variability was described as the standard devia-
tion. The variability was 2.7 (95% limits of agreements 6 5.4) mm for
the OTO, 2.3 (64.6) mm for the ITI, and 2.0 (64.0) mm for the
LELE method. Corresponding coefﬁcients of variability were 6.4, 6.1
and 5.0 per cent. The difference was 4.1 mm between ITI and OTO
(P < .001), 2.0 mm between ITI and LELE (P < .001), and 2.1 mm
between LELE and OTO (P < .001).
Comment: ITI and LELE methods give smaller measures of aortic
diameter than OTO method. The clinical implication for individuals in
screening programs is that patients with borderline enlargement of
aortas are more likely to be included in follow-up protocols if the
OTO method is utilized. Given that men with aortic aneurysms just
below a threshold level of 30 mm may not be considered for follow-
up studies and that follow-up ultrasound studies have no risk, it seems
that for screening purposes the OTO method of assessing aneurysms
would be preferred. This may enter a few more patients into follow-
up screening protocols but potentially limit those who would drop out
of follow-up screening protocols and subsequently reappear with a
ruptured aneurysm.
Early Sac Shrinkage Predicts a Low Risk of Late Complications After
Endovascular Aortic Aneurysm Repair
Goncalves FB, Baderkhan H, Verhagen HJ, et al. Brit J Surg
2014;101:802-10.
Conclusions: Early changes in aneurysm sac diameter following
EVAR are strong predictors of late complications after EVAR. Patients
with major sac shrinkage have a very low risk of complication for up to
5 years.
Summary: Endovascular aneurysm repair (EVAR) is now the pri-
mary mode for abdominal aortic aneurysm management in suitable pa-
tients. There is, however, no consensus on the frequency of post-EVAR
surveillance, method of imaging, or individual adaptation of surveillance
protocols according to risk of complication. Strategies for reduction of
follow-up intensity and intervals are attractive to make the procedure
potentially more cost effective. If patients with low risk of late complica-
tions could be identiﬁed, this may allow tailoring of surveillance to focus
on patients with higher risk and reduce surveillance rates for those at lower
risk. It is generally regarded that shrinkage of the aneurysm is a marker of
successful endovascular aneurysm repair. It may be that patients with early
postoperative shrinkage will experience fewer subsequent complications
and consequently require less intensive surveillance. The study consisted
of patients undergoing EVAR from 2000 to 2011 at three vascular centers.
To be included in the study the patients had to have had two imaging ex-
aminations (one postoperatively and at least another after 6-18 months).
Maximum diameter, complications and secondary interventions during
follow-up were recorded. Patients were then categorized according to early
sac dynamics. The primary endpoint was freedom from late complications.
Secondary endpoints were freedom from secondary intervention, post im-
plantation rupture, and direct (type I and type III) endoleaks. Included in
the study were 597 EVARs (71.1% of all the EVARs performed). No sac
shrinkage was observed in 284 patients (47.6%), moderate shrinkage (5-
9 mm) was observed in 142 patients (23.8%), and major sac shrinkage
(>10 mm) was seen in 171 patients (28.6%). Four years after index imag-
ing, the rate of freedom from complications was 84.3% (95% CI, 78.7-
89.8), 88.1 (95% CI, 80.6-95.5) and 94.4 (95% CI, 90.1-98.7) per cent
respectively. No shrinkage of the sac was an independent risk factor for
late complications compared with major sac shrinkage (HR, 3.11; P <
.001). Moderate compared with major shrinkage (HR, 2.10; P ¼ .022),
early postoperative complications (HR, 3.14; P < .001) and increasing
abdominal aortic aneurysm baseline diameter (HR, 1.02; P ¼ .001)
were also risk factors for late complications. Freedom from secondary in-
terventions and direct endoleaks was greater for patients with major sac
shrinkage.
Comment: Incomplete follow-up after EVAR is a prevalent prob-
lem. This study, therefore, has implications for improving follow-up by
identifying patients in whom speciﬁc efforts at follow-up should be inten-
siﬁed, while at the same time lessening follow-up for individuals at low-
risk for complication. Overall, resources devoted to follow-up can be
potentially applied most intensely where they hopefully result in more efﬁ-
cient and cost-effective use of endovascular technology for management
of aneurysms.The Presence of SDHB Mutations Should Modify Surgical Indications
for Carotid Body Paragangliomas
Ellis RJ, Patel D, Prodanov T, et al. Ann Surg 2014;260:158-62.
Conclusions: A more aggressive surgical approach is warranted in pa-
tients with carotid body tumors with SDHB mutations.
Summary: Carotid body paragangliomas are often associated with
germ line genetic mutations, most commonly involving genes of the succi-
nate dehydrogenase complex (SDHx), (Neumann HP et al, JAMA
2004;292:943-51). There are paraganlioma syndromes numbered 1
through 4 that are associated with succinate dehydrogenase complex muta-
tions SDHD, SDHAF2, SDHC, and SDHB, respectively. Phenotypic dif-
ferences appear distinct depending on the type of SDHx mutation.
SDHDmutations result in a higher incidence of head and neck paraganglio-
mas and a comparatively lower incidence of pheonchromocytomas.
However, the patients with SDHB mutations appear to have more aggres-
sive disease with higher rates of metastasis compared to those with SDHD
mutations. Traditionally, treatment decisions for carotid body tumors are
based on clinical symptoms and tumor size. The aim of this study was to
determine whether the genetic background of the disease should be incorpo-
rated into treatment decision making. The authors performed a retrospective
analysis of 34 patients with carotid body paragangliomas who underwent
genetic testing and surgical treatment. Recurrence was deﬁned by the return
of local-regional disease and/or development of distant metastases. Clinical
characteristics and genetic testing results were analyzed as predictors of
patient outcomes. Thirty-four patients underwent 41 primary carotid body
tumor resections (median follow-up time, 42months; range, 1-293months).
Overall survival was 91.2%. Twelve patients had germ line mutations in
SDHB, while 17 had mutations in SDHD, and 5 had no known mutation.
Surgical resection of larger tumors was associated with more operative com-
plications (odds ratio, 5.4; P¼ .05). Tumor size at resection was signiﬁcantly
smaller in patients with SDHB mutations than in patients with non-SDHB
mutations (2.1 vs 3.3 cm; P ¼ .02). However, patients with a mutation in
the SDHB gene had signiﬁcantly worse disease-free survival compared
with patients without an SDHB gene mutation (P ¼ .03).
Comment: The striking ﬁnding in this study is the relatively poor dis-
ease free survival in patients with SDHBmutations after surgical resection of
what were smaller tumors. Whereas carotid body tumor resection is often
delayed until the tumor reaches 2 cm in size, these data suggest delaying
the resection until the predetermined size of 2 cm or larger does not provide
optimal disease control in patients with SDHB mutation. The data suggests
that a management algorithm that incorporates genetic germ line testing
may be appropriate for patients with carotid body tumors. Patients with
the SDHB might undergo earlier resection. However, those with non-
SDHB mutations or no mutation might undergo resection only for local
symptoms or if there is an endocrinologic functioning tumor. Otherwise,
such patients perhaps can be appropriately managed by active surveillance.
Prospective Evaluation of the Correlation Between Torso Height and
Aortic Anatomy in Respect of a Fluoroscopy-Free Aortic Balloon
Occlusion System
Morrison JJ, Stannard A, Midwinter MJ, et al. Surgery 2014;155:1044-51.
Conclusions: Morphologic analysis can be used in the development
of a ﬂuoroscopy free balloon occlusion system for torso hemorrhage control.
Summary: Endovascular balloon occlusion of the aorta as an adjunct
to circulatory support in patients with cardiovascular collapse from hemor-
rhage, was ﬁrst used in the 1950’s (Hughes C, Surgery 1954;36:65-8).
Additional attempts followed in the 1980’s (Gupta B et al, J Trauma
1989;29:861-5). Technological limitations secondary to arterial access,
balloon construction, and placement in the 1980s resulted in the fact that
despite some favorable outcomes, the technique was not widely adopted.
With improvements in engineering in the endovascular area the use of
REBOA is currently being revisited using off the shelf devises (Brenner
ML et al, J Trauma 2013;75:506-11). Current technology generally re-
quires ﬂuoroscopy for precise placement of a balloon occlusion device. Blind
insertion can be associated with placement in the aortic arch, or in iliac ar-
teries precipitating cerebral ischemia or inadequate hemorrhage control.
The authors propose that a potential solution to aid ﬂuoroscopy-free place-
ment is to use an external anatomic measure to predict internal vascular
length. There has been a previously described linear relationship between
aortic length and torso height (Stannard A et al, J Trauma 2013;75:s169-
72). In this study the authors aim to develop predictive models of REBOA
insertion distance based upon external measure of torso height correlated
with intravascular distance. This was a prospective observational study of a
Combat Support Hospital in Southern Afghanistan, using adult male pa-
tients undergoing computed tomography. Externally measured torso height
(EMTH) was recorded using a tape measure and intra-arterial distance
derived from CT imaging. Regression models to predict distance from the
